Four studies of BC cases have investigated the co-occurrence of carriers of the BARD1 c.1670G>C; p.Cys557Ser variant with pathogenic variants in BRCA1 or BRCA2 [14,15,17,80]. Here, BRCA2 is linked to breast cancer.